Meeting
2017 ASCO Annual Meeting
Differences in systemic and surgical therapy between right (R) and left (L) sided metastatic colorectal cancer (mCRC).
Authors
Hagen F. Kennecke
Department of Medical Oncology, BC Cancer Agency, Vancouver, BC, Canada
Hagen F. Kennecke , Yaling Yin , Jonathan M. Loree , Rachel Leung , Sharlene Gill
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Colorectal) Cancer
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Epidemiology/Outcomes
Citation
J Clin Oncol 35, 2017 (suppl; abstr 3602)
DOI
10.1200/JCO.2017.35.15_suppl.3602
Abstract #
3602
Poster Bd #
225
Abstract Disclosures
Similar Posters
Poster
2017 Gastrointestinal Cancers Symposium
Utilization of systemic therapy options in the routine treatment of metastatic colorectal cancer.
First Author: Rachel Lee Delahunty
Poster
2016 Gastrointestinal Cancers Symposium
Outcomes of perioperative systemic therapy (ST) in patients with R0 resection of metastatic colorectal cancer (mCRC).
First Author: Richard M. Lee-Ying
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Real-world effectiveness and safety of trifluridine-tipiracil (FTD/TPI) and bevacizumab (BEV) in refractory metastatic colorectal cancer (mCRC): The BeTAS trial.
First Author: Nieves Martinez Lago
Poster
2023 ASCO Annual Meeting
Upfront palliative resection of primary tumor versus no resection in patients with synchronous metastatic colorectal cancer: The randomized phase 3 CAIRO4 study of the Dutch Colorectal Cancer Group (DCCG).
First Author: Miriam Koopman